Trial
NCT03154333
Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Castle Creek Pharmaceuticals, LLC
Collaborators
—
Condition
Epidermolysis Bullosa Simplex
Intervention
diacerein 1% ointment
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-05